What is the first‑line treatment for an uncomplicated corneal abrasion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Corneal Abrasion

Start topical fluoroquinolone antibiotic drops (moxifloxacin 0.5% or gatifloxacin 0.5%) four times daily within 24 hours of injury—this is the mandatory first-line treatment for all corneal abrasions to prevent bacterial keratitis and ulceration. 1, 2

Immediate Treatment Protocol

Antibiotic Therapy (Primary Treatment)

  • Fluoroquinolones are the preferred first-line antibiotics because they achieve superior corneal tissue penetration and provide broad-spectrum coverage against both gram-positive and gram-negative organisms 1, 2
  • Apply moxifloxacin 0.5% or gatifloxacin 0.5% drops four times daily until complete epithelial healing is confirmed 1, 3
  • Prophylactic antibiotics prevent ulceration specifically when initiated within 24 hours of the abrasion 1, 2
  • Consider adding antibiotic ointment at bedtime for additional lubrication and protection, though drops are superior for achieving therapeutic corneal tissue levels 1, 2

Pain Management (Adjunctive)

  • Use over-the-counter oral acetaminophen or NSAIDs for pain control 1, 2
  • Topical NSAIDs (if available) significantly reduce pain scores at 24 hours and 48 hours compared to control 4
  • Topical anesthetics may be considered for simple abrasions only—dispense no more than 1.5-2 mL for use every 30 minutes as needed during the first 24 hours only, with any remainder discarded after 24 hours 5

Risk-Stratified Antibiotic Selection

Contact Lens-Related Abrasions (High Risk)

  • Mandatory antipseudomonal fluoroquinolone coverage (moxifloxacin 0.5% or gatifloxacin 0.5%) is required due to dramatically increased Pseudomonas keratitis risk 1, 3
  • Use more aggressive treatment with frequent antibiotic drops 1, 3
  • Never patch the eye in contact lens wearers—this increases bacterial keratitis risk 1, 3
  • Advise complete avoidance of contact lens wear until healing is confirmed by examination 1, 2

Non-Contact Lens Simple Abrasions (Standard Risk)

  • Fluoroquinolone drops (moxifloxacin 0.5% or gatifloxacin 0.5%) four times daily 1, 3
  • Treatment duration continues until complete epithelial healing 1, 3

Critical Management Principles: What NOT to Do

Contraindicated Interventions

  • Eye patching is contraindicated—it does not improve pain, may delay healing, and increases infection risk, especially in contact lens wearers 1, 6, 4
  • Avoid topical corticosteroids initially—they delay healing and increase infection risk 1
  • Do NOT use combination steroid-antibiotic drops as initial therapy 1, 3
  • Steroids should only be added after 2-3 days of antibiotic-only therapy if bacterial infection is controlled 1, 3
  • Never use corticosteroids in suspected Acanthamoeba, Nocardia, or fungal infections—they worsen outcomes 1, 3
  • Do not rub the eye as this worsens the injury and causes further corneal damage 1, 3

Important Caveats

  • Tetracycline ointment lacks adequate corneal penetration and should not be used as monotherapy 3, 2
  • Topical cycloplegics are not beneficial for uncomplicated corneal abrasions 6, 7
  • Chronic prophylactic antibiotic use promotes resistant organisms and should only be used for finite treatment periods during the healing phase 1, 3, 2

Follow-Up Protocol

Routine Follow-Up

  • Small abrasions (≤4 mm) with normal vision and resolving symptoms may not require follow-up 7
  • All other patients require re-evaluation within 24 hours to assess healing and detect early infection 1, 3

Red Flags Requiring Immediate Ophthalmology Referral

  • Central infiltrate >2 mm 1, 3
  • Significant stromal involvement or corneal melting 1, 3
  • Corneal infiltrate with suppuration, necrosis, or feathery margins suggesting bacterial keratitis 1, 3
  • High-velocity eye injuries or penetrating trauma 1, 3
  • Irregular pupil after trauma 1, 3
  • Eye bleeding or loss of vision after trauma 1, 3
  • Increasing pain, purulent discharge, or vision changes despite treatment 1, 3, 2

High-Risk Populations Requiring Enhanced Vigilance

  • Contact lens wearers (especially overnight wear, overwear, inadequate disinfection, swimming/hot tub use with lenses) 1, 3
  • Prior corneal surgery (refractive, cataract, glaucoma surgery, or keratoplasty) 1, 3
  • Chronic ocular surface disease (severe dry eye, entropion, lagophthalmos) 1, 3
  • Immunosuppression or diabetes 1, 3

Treatment Escalation for Bacterial Keratitis

If the abrasion progresses to bacterial keratitis with deep stromal involvement, central location, infiltrate >2 mm, hypopyon, or corneal stromal loss:

  • Obtain cultures before antibiotic initiation 1, 3
  • Initiate loading dose every 5-15 minutes, then hourly dosing 1, 3
  • Consider fortified antibiotics (tobramycin 1.5% + cefazolin 10%) for severe cases 1, 3
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have demonstrated at least equivalent efficacy to fortified combination therapy 1, 3

Special Considerations

  • Inadequate blinking or incomplete eyelid closure during sleep significantly impairs healing—assess this in all patients 8, 2
  • Temporary tarsorrhaphy may be helpful when blinking or lid closure is inadequate 8, 2
  • For persistent epithelial defects, consider bandage contact lens or amniotic membrane 8, 2
  • Increasing resistance of MRSA and Pseudomonas to fluoroquinolones has been documented, highlighting the need for judicious use 1, 3
  • Patient education is essential: instruct patients on infection warning signs (increasing pain, discharge, vision changes) and the need for prompt ophthalmologic care if these develop 1, 3, 2

References

Guideline

Corneal Abrasion Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Corneal Abrasion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetracycline Eye Ointment for Corneal Abrasion Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Topical pain control for corneal abrasions: A systematic review and meta-analysis.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2021

Research

Management of corneal abrasions.

American family physician, 2004

Research

Evaluation and management of corneal abrasions.

American family physician, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.